<DOC>
	<DOCNO>NCT01987947</DOCNO>
	<brief_summary>This multicenter , randomize , double-blind , placebo-controlled , parallel-group study ass efficacy safety additional quilizumab therapy adult patient Chronic Spontaneous Urticaria resistant antihistamine treatment .</brief_summary>
	<brief_title>A Study Quilizumab Versus Placebo Patients With Refractory Chronic Spontaneous Urticaria</brief_title>
	<detailed_description />
	<mesh_term>Urticaria</mesh_term>
	<criteria>Diagnosis CSU refractory H1 antihistamines with/without LTRAs , define follow : The presence itch hive &gt; 6 consecutive week time prior enrollment despite use H1 antihistamine time period UAS7 score great 16 itch component UAS7 great 8 7 day prior Day 1 . Patients must daily stable dos H1 antihistamine least 3 consecutive day immediately prior screen visit must document current use screen CSU diagnose 6 month Patients must minimum diary compliance ( 6 7 consecutive day ) prior Day 1 Treatment investigational agent within 30 day screen , previous treatment monoclonal antibody therapy use treat CSU 9 month prior screen Chronic urticarias CSU , include follow : Acute , solar , cholinergic , heat , cold , aquagenic , delayed pressure contact . Other disease condition symptom urticaria . Routine dos follow medication within 30 day prior screen : systemic topical corticosteroid ( prescription counter ) , hydroxychloroquine , methotrexate , cyclosporine , cyclophosphamide IV immunoglobulin G ( IVIG ) , plasmapheresis within 30 day prior screen Patients cancer , history cancer consider uncured complete remission &lt; 10 year , currently workup suspect cancer except nonmelanoma skin cancer treat excise consider resolved History anaphylactic shock without clearly identifiable avoidable antigen Presence clinically significant cardiovascular , neurological , psychiatric , metabolic pathological condition . Medical examination laboratory finding suggest possibility decompensation coexist condition duration study . Evidence current drug alcohol abuse Nursing woman woman childbearing potential , unless use effective contraception define protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>MEMP1972A</keyword>
</DOC>